JLCYX
Price
$75.23
Change
+$0.08 (+0.11%)
Updated
Sep 8 closing price
Net Assets
6.23B
VTSMX
Price
$155.90
Change
+$0.40 (+0.26%)
Updated
Sep 8 closing price
Net Assets
1.95T
Interact to see
Advertisement

JLCYX vs VTSMX

Header iconJLCYX vs VTSMX Comparison
Open Charts JLCYX vs VTSMXBanner chart's image
JHancock Fundamental Large Cap Core R2
Price$75.23
Change+$0.08 (+0.11%)
VolumeN/A
Net Assets6.23B
Vanguard Total Stock Mkt Idx I
Price$155.90
Change+$0.40 (+0.26%)
VolumeN/A
Net Assets1.95T
JLCYX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JLCYX vs. VTSMX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLCYX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.95T vs. JLCYX (6.23B). VTSMX pays higher dividends than JLCYX: VTSMX (1.07) vs JLCYX (0.15). JLCYX was incepted earlier than VTSMX: JLCYX (14 years) vs VTSMX (33 years). JLCYX (1.17) is less costly to investors than VTSMX (0.14). JLCYX is a more actively managed with annual turnover of: 19.00 vs. VTSMX (2.00). JLCYX has a lower initial minimum investment than VTSMX: JLCYX (0) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 20.08 vs. JLCYX (2.05). VTSMX return over 5 years is better than : 86.56 vs. JLCYX (34.41).
JLCYXVTSMXJLCYX / VTSMX
Total Expense Ratio1.160.14829%
Annual Report Gross Expense Ratio1.170.14836%
Fund Existence14 years33 years-
Gain YTD5.54810.33054%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.23B1.95T0%
Annual Yield % from dividends0.151.0714%
Returns for 1 year2.0520.0810%
Returns for 3 years19.9156.7835%
Returns for 5 years34.4186.5640%
Returns for 10 years81.96225.3936%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WNW1.970.11
+5.65%
Meiwu Technology Company Limited
FDS375.344.33
+1.17%
Factset Research Systems
GMRE7.610.01
+0.13%
Global Medical REIT
ASGN52.43-0.64
-1.21%
ASGN
CRVO9.99-0.52
-4.95%
CervoMed